Follicular Lymphoma: Current Therapeutic Landscape and Future Prospects., PMID:40517443
Advances in the Management of Relapsed/Refractory CLL and Richter Transformation., PMID:40517442
T-Cell Redirecting Strategies in Large B-Cell Lymphoma and Follicular Lymphoma., PMID:40517438
A Phase 2 Study of Obinutuzumab Combined with Lenalidomide in Previously Untreated High Tumor Burden Follicular Lymphoma., PMID:40517417
Cas9- and Cas12a-mediated excision and replacement of the celiac disease-related α-gliadin immunogenic complex in hexaploid wheat., PMID:40517395
Investigation of the Efficacy and Safety of Xeligekimab (GR1501) in Patients with Moderate-to-Severe Plaque Psoriasis: A Multicenter, Randomized, Double-Blind Phase II Clinical., PMID:40517362
Assessment of Lyme Seroconversion Among US Military Personnel in Honduras., PMID:40517326
Therapeutic Effect of Galactosyltransferase- and Sialyltransferase-encoding mRNA in Rheumatoid Arthritis., PMID:40517291
Positive coactivator PC4 shows dynamic nucleolar distribution required for rDNA transcription and protein synthesis., PMID:40517275
Quantitative response assessment of combined immunotherapy in a murine melanoma model using multiparametric MRI., PMID:40517176
Doubling multiplexed imaging capability via spatial expression pattern-guided protein pairing and computational unmixing., PMID:40517167
Advances in molecular pathology and therapy of non-small cell lung cancer., PMID:40517166
Enhanced visualization of colonic polyps using a fluorophore-conjugated claudin-1 antibody in a CPC-APC mouse model., PMID:40517099
Evaluating the Role of CAR-T Cell Therapy in the Context of Current Therapy Options for Patients With Relapsed or Refractory Follicular Lymphoma., PMID:40516919
The Role of Tumor Microenvironment and Immune Cell Crosstalk in Triple-Negative Breast Cancer (TNBC): Emerging Therapeutic Opportunities., PMID:40516902
Potential blocker of SARS-CoV entry and a narrow functionality of its spike protein motifs on Qubevirus platform., PMID:40516871
Nanobodies targeting EGFR provide insight into conformations stabilized by glioblastoma mutations., PMID:40516870
A pooled analysis of datopotamab deruxtecan in patients with EGFR-mutated NSCLC., PMID:40516821
Genomic profiles of pathogenic and moderate-penetrance germline variants associated with risk of early-onset lung adenocarcinoma., PMID:40516820
Decreased pathogenicity of triple-mutant of Aeromonas hydrophila flgK, flgL, flgE suggests its potential as a live attenuated vaccine for Carassius auratus., PMID:40516799
Current and emerging strategies for subcutaneous delivery of high-concentration and high-dose antibody therapeutics., PMID:40516697
Efficacy of waitlist desensitization for lung candidates is limited by antibody rebound., PMID:40516662
Analytical Comparison of Commonly Used Laboratory-Developed Tests for the Assessment of Ki-67 in Breast Carcinoma With an FDA-Approved Benchmark., PMID:40516608
WAYPOINT: Are we there yet for patients with nasal polyposis?, PMID:40516522
Modular high-throughput platform for the purification of scFvs and multispecific antibody-based therapeutics., PMID:40516489
Evaluation of commercial vaccines for efficacy and transmission control against the emergent H5N8 (clade 2.3.4.4b) avian influenza virus in Kazakhstan., PMID:40516487
CD38-targeted antibody-polymer drug conjugates for enhanced treatment of multiple myeloma., PMID:40516447
Fixed dosing versus weight-based dosing of HIV-1 prophylactic monoclonal antibodies in adults: a post-hoc, cross-protocol pharmacokinetics modelling study., PMID:40516378
Identification of candidate vaccine antigens using 2-D gel electrophoresis and immunoproteomics for cross protection against Glaesserella parasuis., PMID:40516376
A fc-engineered NKG2D × B7-H3 bispecific antibody enhances the antitumor activity by orchestrating cytotoxic lymphocytes., PMID:40516256
Diagnostic significance of carcinoembryonic antigen and anti-MDA5 antibodies in polymyositis/dermatomyositis-associated rapidly progressive interstitial lung disease., PMID:40516211
Combined use of Carfilzomib and plasmapheresis in antibody-mediated liver transplant rejection., PMID:40516200
Trop-2 expression as a biomarker of response to sacituzumab govitecan in patients with HER2-negative metastatic breast cancer: A pilot study., PMID:40516178
Cost-Effectiveness Analysis of Universal Screening for Subclinical Hypothyroidism in Pregnancy Based on the Czech Nation-Wide Pilot Screening Program in Light of Current Evidence., PMID:40516156
Common Toll-like receptor 7 variants define disease risk and phenotypes in juvenile-onset systemic lupus erythematosus., PMID:40516124
Transplants foster B cell alloimmunity by relaying extracellular vesicles to follicular dendritic cells., PMID:40516053
Transient glycan shield reduction induces CD4-binding site broadly neutralizing antibodies in SHIV-infected macaques., PMID:40516049
m6A-REFII: an antibody-independent tool for in situ visualizing cellular specific RNA m6A compatible with protein immunofluorescence staining., PMID:40516020
The immune response of Boschveld chickens to a Newcastle disease vaccination program designed for commercial layers., PMID:40515962
Prevalence and clinical significance of autoantibodies to sulphite oxidase and glycogen phosphorylase in Chinese primary biliary cholangitis patients., PMID:40515960
RNA-Binding Protein Immunoprecipitation 1 (RIP) Assay to Investigate the Interactions Between Viral RNA and Host Proteins., PMID:40515923
Determination of Protein Ubiquitination After Protein Denaturation in Virus-Host Interactions., PMID:40515897
Beyond BCL2 (B cell lymphoma) and BTK (Bruton tyrosine kinase) inhibitors: novel agents and resistance mechanisms for chronic lymphocytic leukemia., PMID:40515863
Response to telitacicept in optic neuritis associated with Sjogren's syndrome: a case report and literature review., PMID:40515854
Basal cell adenoma with S100 protein-positive "stroma": a distinct triphasic salivary gland neoplasm characterized by CTNNB1 mutation., PMID:40515848
Effectiveness and safety of ravulizumab for Japanese patients with atypical hemolytic uremic syndrome switched from eculizumab: an analysis of a post-marketing surveillance., PMID:40515788
The Immunology of Alpha-Gal Syndrome: History, Tick Bites, IgE, and Delayed Anaphylaxis to Mammalian Meat., PMID:40515672
A comparison of JC virus assay performance provided with originator and biosimilar natalizumab., PMID:40515643
Beyond the switch to the biosimilar of natalizumab: What is the impact of changing the JCV test?, PMID:40515642
Diagnostic uncertainty in the era of biosimilar natalizumab-The case for harmonizing anti-JCV antibody testing., PMID:40515640
For research use only. Not for human or drug use.
